will fda ban compounded semaglutide 🚨 Moves to Permanently Shut Down GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these Compounded Semaglutide: Legal & Safe

Given the benefits of this class of medication, it is likely more approvals for more indications will be on the horizon

Just this month, on January 29, 2026, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) issued an important update for patients and prescribers

One trial has already finished

The video call is required after the initial async option, with a $30 charge for the appointment

[8] [9] It is worth noting that whilst these strategies support overall metabolic health, they are not substitutes for prescribed medication when clinically indicated

Its triple-receptor action may provide more comprehensive effects than single-target medications